Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Phase II Trial of Oral Topotecan and Paclitaxel With G-CSF (Filgrastim) Support in Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  7/12/2016
CCOP - Merit Care Hospital
mi
from
Fargo, ND
Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Phase II Trial of Oral Topotecan and Paclitaxel With G-CSF (Filgrastim) Support in Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 7/12/2016
CCOP - Merit Care Hospital
mi
from
Fargo, ND
Click here to add this to my saved trials
Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Phase II Trial of Oral Topotecan and Paclitaxel With G-CSF (Filgrastim) Support in Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  7/12/2016
Altru Health Systems
mi
from
Grand Forks, ND
Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Phase II Trial of Oral Topotecan and Paclitaxel With G-CSF (Filgrastim) Support in Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 7/12/2016
Altru Health Systems
mi
from
Grand Forks, ND
Click here to add this to my saved trials
Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Phase II Trial of Oral Topotecan and Paclitaxel With G-CSF (Filgrastim) Support in Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  7/12/2016
CCOP - Toledo Community Hospital Oncology Program
mi
from
Toledo, OH
Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Phase II Trial of Oral Topotecan and Paclitaxel With G-CSF (Filgrastim) Support in Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 7/12/2016
CCOP - Toledo Community Hospital Oncology Program
mi
from
Toledo, OH
Click here to add this to my saved trials
Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Phase II Trial of Oral Topotecan and Paclitaxel With G-CSF (Filgrastim) Support in Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  7/12/2016
CCOP - Geisinger Clinical and Medical Center
mi
from
Danville, PA
Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Phase II Trial of Oral Topotecan and Paclitaxel With G-CSF (Filgrastim) Support in Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 7/12/2016
CCOP - Geisinger Clinical and Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Phase II Trial of Oral Topotecan and Paclitaxel With G-CSF (Filgrastim) Support in Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  7/12/2016
Rapid City Regional Hospital
mi
from
Rapid City, SD
Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Phase II Trial of Oral Topotecan and Paclitaxel With G-CSF (Filgrastim) Support in Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 7/12/2016
Rapid City Regional Hospital
mi
from
Rapid City, SD
Click here to add this to my saved trials
Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Phase II Trial of Oral Topotecan and Paclitaxel With G-CSF (Filgrastim) Support in Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  7/12/2016
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Topotecan, Paclitaxel, and Filgrastim in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Phase II Trial of Oral Topotecan and Paclitaxel With G-CSF (Filgrastim) Support in Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 7/12/2016
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
UCSF Cancer Center and Cancer Research Institute
mi
from
San Francisco, CA
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
UCSF Cancer Center and Cancer Research Institute
mi
from
San Francisco, CA
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
Morton Plant Mease Health Care
mi
from
Clearwater, FL
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
Morton Plant Mease Health Care
mi
from
Clearwater, FL
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
Lakeland Regional Medical Center
mi
from
Lakeland, FL
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
Lakeland Regional Medical Center
mi
from
Lakeland, FL
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
University of Chicago Cancer Research Center
mi
from
Chicago, IL
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
University of Chicago Cancer Research Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
Lutheran General Hospital
mi
from
Park Ridge, IL
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
Lutheran General Hospital
mi
from
Park Ridge, IL
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
Indiana University Cancer Center
mi
from
Indianapolis, IN
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
Indiana University Cancer Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
Holden Comprehensive Cancer Center
mi
from
Iowa City, IA
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
Holden Comprehensive Cancer Center
mi
from
Iowa City, IA
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
Veterans Affairs Medical Center - Iowa City
mi
from
Iowa City, IA
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
Veterans Affairs Medical Center - Iowa City
mi
from
Iowa City, IA
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
Marlene & Stewart Greenebaum Cancer Center, University of Maryland
mi
from
Baltimore, MD
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
Marlene & Stewart Greenebaum Cancer Center, University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
Massachusetts General Hospital Cancer Center
mi
from
Boston, MA
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
Massachusetts General Hospital Cancer Center
mi
from
Boston, MA
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
William Beaumont Hospital
mi
from
Royal Oak, MI
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
William Beaumont Hospital
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
Barnes Jewish Hospital
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
Mount Sinai School of Medicine
mi
from
New York, NY
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
Duke Comprehensive Cancer Center
mi
from
Durham, NC
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
Duke Comprehensive Cancer Center
mi
from
Durham, NC
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
Westmoreland Hospital
mi
from
Greensburg, PA
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
Westmoreland Hospital
mi
from
Greensburg, PA
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
Jameson Memorial Hospital
mi
from
New Castle, PA
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
Jameson Memorial Hospital
mi
from
New Castle, PA
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
Allegheny General Hospital
mi
from
Pittsburgh, PA
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
Allegheny General Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
Western Pennsylvania Cancer Institute
mi
from
Pittsburgh, PA
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
Western Pennsylvania Cancer Institute
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
Medical University of South Carolina
mi
from
Charleston, SC
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
Latter Day Saints Hospital
mi
from
Salt Lake City, UT
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
Latter Day Saints Hospital
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated:  7/12/2016
Massey Cancer Center
mi
from
Richmond, VA
Positron Emission Tomography for Detecting Non-small Cell Lung Cancer
The Utility of Positron Emission Tomography (PET) in Staging of Patients With Potentially Operable Non-Small Cell Lung Carcinoma
Status: Enrolling
Updated: 7/12/2016
Massey Cancer Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated:  7/12/2016
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated: 7/12/2016
CCOP - Scottsdale Oncology Program
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated:  7/12/2016
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated: 7/12/2016
Mayo Clinic, Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated:  7/12/2016
Illinois Oncology Research Association
mi
from
Peoria, IL
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated: 7/12/2016
Illinois Oncology Research Association
mi
from
Peoria, IL
Click here to add this to my saved trials
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated:  7/12/2016
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated: 7/12/2016
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Click here to add this to my saved trials
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated:  7/12/2016
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated: 7/12/2016
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated:  7/12/2016
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated: 7/12/2016
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Click here to add this to my saved trials
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated:  7/12/2016
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated: 7/12/2016
Siouxland Hematology-Oncology
mi
from
Sioux City, IA
Click here to add this to my saved trials
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated:  7/12/2016
CCOP - Wichita
mi
from
Wichita, KA
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated: 7/12/2016
CCOP - Wichita
mi
from
Wichita, KA
Click here to add this to my saved trials
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated:  7/12/2016
CCOP - Duluth
mi
from
Duluth, MN
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated: 7/12/2016
CCOP - Duluth
mi
from
Duluth, MN
Click here to add this to my saved trials
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated:  7/12/2016
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated: 7/12/2016
Mayo Clinic Cancer Center
mi
from
Rochester, MN
Click here to add this to my saved trials
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated:  7/12/2016
CentraCare Clinic
mi
from
Saint Cloud, MN
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated: 7/12/2016
CentraCare Clinic
mi
from
Saint Cloud, MN
Click here to add this to my saved trials
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated:  7/12/2016
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated: 7/12/2016
CCOP - Metro-Minnesota
mi
from
Saint Louis Park, MN
Click here to add this to my saved trials
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated:  7/12/2016
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated: 7/12/2016
CCOP - Missouri Valley Cancer Consortium
mi
from
Omaha, NE
Click here to add this to my saved trials
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated:  7/12/2016
CCOP - Merit Care Hospital
mi
from
Fargo, ND
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated: 7/12/2016
CCOP - Merit Care Hospital
mi
from
Fargo, ND
Click here to add this to my saved trials
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated:  7/12/2016
CCOP - Toledo Community Hospital Oncology Program
mi
from
Toledo, OH
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated: 7/12/2016
CCOP - Toledo Community Hospital Oncology Program
mi
from
Toledo, OH
Click here to add this to my saved trials
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated:  7/12/2016
CCOP - Geisinger Clinic and Medical Center
mi
from
Danville, PA
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated: 7/12/2016
CCOP - Geisinger Clinic and Medical Center
mi
from
Danville, PA
Click here to add this to my saved trials
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated:  7/12/2016
Rapid City Regional Hospital
mi
from
Rapid City, SD
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated: 7/12/2016
Rapid City Regional Hospital
mi
from
Rapid City, SD
Click here to add this to my saved trials
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated:  7/12/2016
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
Aerosolized GM-CSF in the Treatment of Metastatic Melanoma to the Lung
Status: Enrolling
Updated: 7/12/2016
CCOP - Sioux Community Cancer Consortium
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study of 9 Nitrocamptothecin for Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/12/2016
Veterans Affairs Medical Center - Birmingham
mi
from
Birmingham, AL
Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study of 9 Nitrocamptothecin for Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/12/2016
Veterans Affairs Medical Center - Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study of 9 Nitrocamptothecin for Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/12/2016
University of California San Diego Cancer Center
mi
from
La Jolla, CA
Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study of 9 Nitrocamptothecin for Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/12/2016
University of California San Diego Cancer Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study of 9 Nitrocamptothecin for Hormone Refractory Prostate Cancer
Status: Enrolling
Updated:  7/12/2016
UCSF Cancer Center and Cancer Research Institute
mi
from
San Francisco, CA
Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy
A Phase II Study of 9 Nitrocamptothecin for Hormone Refractory Prostate Cancer
Status: Enrolling
Updated: 7/12/2016
UCSF Cancer Center and Cancer Research Institute
mi
from
San Francisco, CA
Click here to add this to my saved trials